These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3751789)

  • 1. [Plasma fibrinopeptide A and fibrinopeptide B beta 15-42 levels in patients with Behçet's disease].
    Sunakawa M; Arai I; Okinami S
    Nippon Ganka Gakkai Zasshi; 1986 Jun; 90(6):871-4. PubMed ID: 3751789
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinopeptide A and fibrinopeptide B beta 15-42 in patients with Behçet's disease.
    Sunakawa M; Okinami S
    Metab Pediatr Syst Ophthalmol (1985); 1988; 11(4):147-8. PubMed ID: 3221795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of fibrinopeptide A and B beta 15-42 analysis in blood coagulo-fibrinolytic tests].
    Koshihara K; Fuzimaki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():889-91. PubMed ID: 2622023
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serial changes in FPA and FPB beta 15-42 during surgery with cardiopulmonary bypass].
    Gando S; Tedo I; Tsujinaga H; Kubota M
    Masui; 1988 May; 37(5):541-5. PubMed ID: 3411777
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma concentrations of fibrinopeptide A and fibrinopeptide B beta 15-42 in glomerulonephritis and the nephrotic syndrome.
    Tomura S; Oono Y; Kuriyama R; Takeuchi J
    Arch Intern Med; 1985 Jun; 145(6):1033-5. PubMed ID: 4004427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of fibrinopeptide A (FPA) and fibrinopeptide B beta 15-42 (FPB beta) in urine and plasma after urokinase administration in patients with chronic glomerulonephritis.
    Miura M; Tomino Y; Inoue W; Yagame M; Tamura S; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1986 Oct; 11(4):273-7. PubMed ID: 3617111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrinopeptide A (FPA), fibrinopeptide B (FPB) and fibrinopeptide Bbeta(15-42) (FPBbeta15-42)].
    Uchiba M; Okajima K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():615-7. PubMed ID: 15658404
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood coagulation and fibrinolysis in anesthesia and operations, with special reference to FPA, FPB beta 15-42].
    Gando S; Tedo I; Hanaoka Y; Makise N; Tsujinaga H; Kubota M
    Masui; 1988 Apr; 37(4):451-6. PubMed ID: 3398226
    [No Abstract]   [Full Text] [Related]  

  • 9. [Coagulation-fibrinolysis abnormalities in acute stage hypertensive intra-cerebral hemorrhage and head injury (preliminary report). With special reference to fibrinopeptides A and B beta 15-42].
    Touho H; Hino A; Suzuki K; Kubo S; Hirakawa K
    Neurol Med Chir (Tokyo); 1985 Mar; 25(3):203-8. PubMed ID: 2409465
    [No Abstract]   [Full Text] [Related]  

  • 10. "Falsely increased" B beta 15-42 levels in diabetes.
    Marongiu F; Conti M; Mameli G; Sorano GG; Cirillo R; Balestrieri A
    Diabetes Care; 1990 Nov; 13(11):1129-30. PubMed ID: 2082993
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinopeptide A and B beta 15-42 in liver cirrhosis.
    Marongiu F; Mameli G; Acca MR; Mulas G; Medda A; Tronci MB; Mamusa AM; Balestrieri A
    Haemostasis; 1988; 18(2):126-8. PubMed ID: 2457543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer.
    McCulloch P; Douglas J; Lowe GD; Murray G; George WD
    Thromb Haemost; 1989 Apr; 61(2):318-21. PubMed ID: 2749603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of acid-base balance and Apgar score on fibrinopeptide A and fibrinopeptide B beta 15-42 in umbilical cord blood].
    Ogura H; Adachi H; Takeda T; Nakagomi H; Kanno S; Yokoyama M; Kinoshita T
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):128-34. PubMed ID: 3102647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma fibrinopeptide A, fibrinopeptide B beta 15-42 and 4 other coagulation factors levels in patients with diabetic retinopathy].
    Yamamoto M; Denno S; Sunakawa M
    Nippon Ganka Gakkai Zasshi; 1992 Nov; 96(11):1443-8. PubMed ID: 1476075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic markers in acute stroke.
    Feinberg WM; Bruck DC; Ring ME; Corrigan JJ
    Stroke; 1989 May; 20(5):592-7. PubMed ID: 2718198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemostatic changes and the hypercoagulable state.
    Lowe GD
    Lancet; 1991 Dec; 338(8781):1526. PubMed ID: 1683945
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction.
    Lawler CM; Bovill EG; Stump DC; Collen DJ; Mann KG; Tracy RP
    Blood; 1990 Oct; 76(7):1341-8. PubMed ID: 2119827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is a hypercoagulable state present in hypothyroidism?
    Marongiu F; Biondi G; Conti M; Murtas ML; Mameli G; Sorano GG; Martino E
    Thromb Haemost; 1992 Jun; 67(6):729. PubMed ID: 1509420
    [No Abstract]   [Full Text] [Related]  

  • 19. Structural considerations of plasmic degradation of fibrinogen.
    Marder VJ; Budzynski AZ
    Pathol Biol (Paris); 1974 Nov; 22 suppl():43-6. PubMed ID: 4283397
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical tests on the diagnosis of thrombosis].
    Yamanaka M
    Nihon Rinsho; 1986 May; 44(5):1076-80. PubMed ID: 2943914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.